Glycemic treatments by therapeutic category
| Insulin sensitizers Biguanide: metfomin (Fortamet, Glucophage, Glumetza, Riomet) Thiazolidinedione: pioglitazone (Actos), rosiglitazone (Avandia) Insulin secretagogues Sulfonylureas: chlorpropamide (Diabinese), glimepiride (Amaryl), glipizide (Glucotrol), glyburide (Micronase, Glynase) Glinides: repaglinide (Prandin), nateglinide (Starlix) Alpha-glucosidase inhibitors Acarbose (Precose), miglitol (Glyset), voglibose Incretin-based therapies Glucagon-like peptide-1 agonists: albiglutide (Tanzeum), dulaglutide (Trulicity), exenatide (Bydureon, Byetta), liraglutide (Saxenda, Victoza), lixisenatide (Adlyxin) Dipeptidyl peptidase-4 inhibitors: alogliptin (Nesina), linagliptin (Tradjenta), saxagliptin (Onglyza), sitagliptin (Januvia) Sodium-glucose transporter-2 inhibitors Canagliflozin (Invokana), dapagliflozin (Farxiga), empagliflozin (Jardiance) Amylinomimetic Pramlintide (SymlinPen 120, SymlinPen 60) | Dopamine agonist Bromocriptine (Cycloset) Insulin Rapid-acting Aspart insulin (Novolog) Glulisine insulin (Apidra) Lispro insulin (Humalog) Short-acting Regular insulin (HumuLIN R, HumuLIN R U-500 KwikPen, NovoLIN R, NovoLIN R ReliOn) Intermediate-acting Isophane insulin, NPH insulin (Humulin N, Novolin N) Long-acting Detemir insulin (Levemir) Glargine insulin (Basaglar KwikPen, Lantus, Lantus SoloStar, Toujeo SoloStar) Degludec insulin (Tresiba) Premixed Several types intermediate-acting and short-acting insulin combined are available |
Based on information from the American Diabetes Association8 and Inzucchi et al.12